News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
107,813 Results
Type
Article (4249)
Company Profile (18)
Press Release (103546)
Section
Business (31969)
Career Advice (108)
Deals (5250)
Drug Delivery (5)
Drug Development (5402)
Employer Resources (11)
FDA (3199)
Job Trends (2077)
News (46953)
Policy (3871)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 BioMidwest Digital (3)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
Academia (363)
Allergies (9)
Alliances (11161)
ALS (6)
Alzheimer's disease (310)
Antibody-drug conjugate (ADC) (3)
Approvals (3210)
Artificial intelligence (85)
Automation (3)
Bankruptcy (46)
Best Places to Work (1719)
Biosimilars (7)
Biotechnology (10)
Bladder cancer (9)
Brain cancer (5)
Breast cancer (57)
Cancer (391)
Cardiovascular disease (24)
Career advice (99)
Career pathing (1)
CAR-T (9)
Cell therapy (22)
Cervical cancer (7)
Clinical research (4177)
Collaboration (166)
Compensation (16)
COVID-19 (480)
C-suite (34)
Cystic fibrosis (8)
Data (238)
Decentralized trials (1)
Depression (4)
Diabetes (16)
Diagnostics (5795)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (13)
Drug pricing (3)
Drug shortages (1)
Duchenne muscular dystrophy (5)
Earnings (10438)
Employer branding (2)
Employer resources (11)
Events (13505)
Executive appointments (103)
FDA (3376)
Featured Employer (2)
Fibrodysplasia Ossificans Progressiva (1)
Funding (120)
Gene editing (1)
Generative AI (8)
Gene therapy (13)
GLP-1 (40)
Government (624)
Guidances (5)
Healthcare (2908)
IgA nephropathy (1)
Immunology and inflammation (6)
Indications (2)
Infectious disease (507)
Inflammatory bowel disease (12)
Influenza (11)
Intellectual property (6)
Interviews (12)
IPO (1796)
IRA (1)
Job creations (401)
Job search strategy (94)
Kidney cancer (4)
Labor market (1)
Layoffs (24)
Leadership (1)
Legal (533)
Liver cancer (11)
Lung cancer (45)
Lymphoma (28)
Machine learning (1)
Management (3)
Manufacturing (42)
MASH (4)
Medical device (2455)
Medtech (2455)
Mergers & acquisitions (3535)
Metabolic disorders (33)
Multiple sclerosis (19)
NASH (3)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (364)
NextGen: Class of 2025 (703)
Non-profit (547)
Northern California (335)
Now hiring (2)
Obesity (13)
Opinion (11)
Ovarian cancer (13)
Pain (3)
Pancreatic cancer (10)
Parkinson's disease (14)
Partnered (3)
Patents (19)
Patient recruitment (9)
Peanut (4)
People (8958)
Pharmaceutical (1)
Phase I (1261)
Phase II (1751)
Phase III (1604)
Pipeline (118)
Podcasts (1)
Policy (1)
Postmarket research (212)
Preclinical (591)
Press Release (11)
Prostate cancer (33)
Psychedelics (1)
Radiopharmaceuticals (121)
Rare diseases (28)
Real estate (863)
Recruiting (5)
Regulatory (3005)
Reports (10)
Research institute (425)
Resumes & cover letters (15)
Rett syndrome (1)
Schizophrenia (1)
Series A (15)
Series B (12)
Service/supplier (2)
Sickle cell disease (1)
Southern California (266)
Spinal muscular atrophy (10)
Sponsored (5)
Startups (623)
Stomach cancer (2)
Supply chain (4)
The Weekly (1)
United States (2937)
Vaccines (39)
Venture capitalists (6)
Weight loss (4)
Women's health (6)
Date
Today (18)
Last 7 days (104)
Last 30 days (350)
Last 365 days (5027)
2025 (1337)
2024 (5131)
2023 (6128)
2022 (10208)
2021 (9617)
2020 (8992)
2019 (6146)
2018 (4852)
2017 (5399)
2016 (5389)
2015 (6109)
2014 (4630)
2013 (4126)
2012 (4435)
2011 (4630)
2010 (4080)
Location
Africa (131)
Alabama (6)
Alaska (1)
Arizona (54)
Arkansas (2)
Asia (5322)
Australia (1246)
California (720)
Canada (250)
China (30)
Colorado (49)
Connecticut (60)
Delaware (6)
Europe (15156)
Florida (94)
Georgia (37)
Idaho (4)
Illinois (94)
India (4)
Indiana (31)
Iowa (3)
Japan (21)
Kansas (11)
Kentucky (4)
Louisiana (1)
Maine (20)
Maryland (94)
Massachusetts (389)
Michigan (64)
Minnesota (71)
Missouri (28)
Montana (4)
Nebraska (8)
Nevada (1)
New Hampshire (18)
New Jersey (137)
New Mexico (17)
New York (283)
North Carolina (178)
North Dakota (6)
Northern California (335)
Ohio (28)
Oklahoma (2)
Oregon (7)
Pennsylvania (78)
Rhode Island (4)
South America (154)
South Carolina (3)
Southern California (266)
Tennessee (27)
Texas (164)
Utah (76)
Virginia (35)
Washington D.C. (6)
Washington State (66)
Wisconsin (29)
107,813 Results for "sqi diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
SQI Diagnostics Reports Second Quarter 2023 Results
SQI Diagnostics Inc. (“SQI” or the “Company”) (TSXV: SQD) (OTCQB: SQIDF), a leader in the science of lung health that develops and manufactures respiratory health and precision medicine tests today reported its financial and operational results for the second quarter ended March 31, 2022.
May 30, 2023
·
7 min read
Four Diagnostic Products in the Pipeline at SQI
SQI Diagnostics Inc. announced it is developing three diagnostic products based on University Health Network innovations and is exploring an initiative with Owlstone Medical and UHN on a fourth diagnostic product.
March 3, 2023
·
9 min read
Business
SQI Diagnostics Reports Internal Restructuring
SQI Diagnostics Inc., a leader in the science of lung health that develops and manufactures respiratory health and precision medicine tests announced that the Company’s board of directors has issued layoff notices to each of Andrew Morris, the Company’s Chief Executive, and Eric Brouwer, the Company’s Chief Scientific Officer, in an effort to further reduce the Company’s expenses.
June 6, 2023
·
5 min read
Business
SQI Diagnostics Announces New Capital Markets Consulting Agreement
SQI Diagnostics Inc. today announces that it has entered into a new consulting agreement with Looking Glass Capital Consultants.
March 13, 2023
·
3 min read
Business
SQI Diagnostics Reports First Quarter 2023 Results
SQI Diagnostics Inc., a leader in the science of lung health that develops and manufactures respiratory health and precision medicine tests reported its financial and operational results for the first quarter ended December 31, 2022.
March 1, 2023
·
6 min read
Deals
SQI Diagnostics Announces Receipt of Intention to Enforce Security from Pivot Financial and Anticipated Voluntary Bankruptcy Filing
SQI Diagnostics Inc. announced that the Company’s board of directors has received a notice of intention to enforce security issued by its senior secured creditor, Pivot Financial I Limited Partnership, under Section 244 of the Bankruptcy and Insolvency Act.
June 16, 2023
·
5 min read
Deals
SQI DIAGNOSTICS ANNOUNCES PROPOSED INSIDER SALES AND WARRANT EXERCISES TO FUND COMPANY
SQI Diagnostics Inc. announces that certain insiders of the Company, who are also control persons of the Company and collectively own, or exercise control or direction over, an aggregate of 75% of the issued and outstanding common shares.
March 24, 2023
·
4 min read
Business
SQI Diagnostics Reports Fourth Quarter and Fiscal 2022 Results
SQI Diagnostics Inc., a leader in the science of lung health that develops and manufactures respiratory health and precision medicine tests reported its financial and operational results for the fourth quarter and fiscal year ended September 30, 2022.
January 30, 2023
·
6 min read
Business
SQI Diagnostics Reports Third Quarter 2022 Results
SQI Diagnostics Inc. today reported its financial and operational results for the third quarter for fiscal year ending September 30, 2022.
August 29, 2022
·
5 min read
SQI Diagnostics Secures Up To $2 Million in FedDev Ontario Funding
SQI Diagnostics Inc. (“SQI” or the “Company”) (TSX-V: SQD) (OTCQB: SQIDF) today announced that it has entered into a funding agreement (the “Contribution Agreement”) with the Federal Economic Development Agency for Southern Ontario (“FedDev Ontario”) to support the Company’s manufacturing scale-up and commercialization of its pipeline of products in development, including the Company’s recently approved RALI-DX IL-6 test.
November 10, 2022
·
4 min read
1 of 10,782
Next